10-100526465-G-T
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005004.4(NDUFB8):c.402C>A(p.Phe134Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000744 in 1,612,418 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_005004.4 missense
Scores
Clinical Significance
Conservation
Publications
- mitochondrial complex I deficiency, nuclear type 32Inheritance: AR, Unknown Classification: STRONG, MODERATE, LIMITED Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- Leigh syndromeInheritance: AR Classification: MODERATE Submitted by: ClinGen
- Leigh syndrome with cardiomyopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| NDUFB8 | NM_005004.4 | c.402C>A | p.Phe134Leu | missense_variant | Exon 4 of 5 | ENST00000299166.9 | NP_004995.1 | |
| NDUFB8 | NM_001284367.2 | c.402C>A | p.Phe134Leu | missense_variant | Exon 4 of 5 | NP_001271296.1 | ||
| NDUFB8 | NM_001284368.1 | c.309C>A | p.Phe103Leu | missense_variant | Exon 4 of 5 | NP_001271297.1 | 
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt | 
|---|---|---|---|---|---|---|---|---|---|---|
| NDUFB8 | ENST00000299166.9 | c.402C>A | p.Phe134Leu | missense_variant | Exon 4 of 5 | 1 | NM_005004.4 | ENSP00000299166.4 | ||
| ENSG00000255339 | ENST00000557395.5 | n.402C>A | non_coding_transcript_exon_variant | Exon 4 of 10 | 2 | ENSP00000456832.1 | 
Frequencies
GnomAD3 genomes  0.0000131  AC: 2AN: 152196Hom.:  0  Cov.: 32 show subpopulations 
GnomAD2 exomes  AF:  0.00000401  AC: 1AN: 249474 AF XY:  0.00   show subpopulations 
GnomAD4 exome  AF:  0.00000685  AC: 10AN: 1460222Hom.:  0  Cov.: 30 AF XY:  0.00000688  AC XY: 5AN XY: 726448 show subpopulations 
Age Distribution
GnomAD4 genome  0.0000131  AC: 2AN: 152196Hom.:  0  Cov.: 32 AF XY:  0.0000134  AC XY: 1AN XY: 74356 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Uncertain:1 
In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This sequence change replaces phenylalanine with leucine at codon 134 of the NDUFB8 protein (p.Phe134Leu). The phenylalanine residue is moderately conserved and there is a small physicochemical difference between phenylalanine and leucine. This variant is not present in population databases (ExAC no frequency). This variant has not been reported in the literature in individuals with NDUFB8-related conditions. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The leucine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at